Showing results (511-520 of 533) with videos related to

Sort By:
Pageof 54
Health Technology Assessment (Winchester, England)|April 30, 2019
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCTAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Journal of Visualized Experiments : Jove|August 15, 2015
Atomically Traceable Nanostructure FabricationJosh B Ballard, Don D Dick, Stephen J McDonnell, et al.
Ebiomedicine|November 6, 2022
Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2Xiao Hu, Yanli Zou, David A Copland, et al.
JAMA Ophthalmology|July 18, 2024
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical TrialSunil K Srivastava, Timothy R Watkins, Quan Dong Nguyen, et al.
Genes, Brain, and Behavior|May 5, 2012
Family-based genome-wide association study of frontal θ oscillations identifies potassium channel gene KCNJ6S J Kang, M Rangaswamy, N Manz, et al.
Ocular Immunology and Inflammation|July 18, 2018
Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II TrialsHiroshi Goto, Masahiro Zako, Kenichi Namba, et al.
Trials|February 2, 2008
Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trialRathie Rajendram, Richard W J Lee, Mike J Potts, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2020
Reducing pain and distress related to needle procedures in children with cancer: A clinical practice guidelineErik A H Loeffen, Renée L Mulder, Anna Font-Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine ALauren P Schewitz-Bowers, Philippa J P Lait, David A Copland, et al.
Nature Medicine|April 21, 2015
Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory diseaseMyriam Chimen, Helen M McGettrick, Bonita Apta, et al.
Pageof 54